Maeve in Karakalpakstan

Javascript is required to view this map.

From Co. Dublin, Maeve Lalor works as an Epidemiologist for the Multi Drug Resistant Tuberculosis (MDR-TB) Directly observed treatment shortcourse (DOTS ) Plus project in Nukus, Uzbekistan. A graduate of UCD, Maeve previously worked at the London School of Hygiene and Tropical Medicine where she completed her PhD on Population Differences in Immune Responses to BCG vaccination.  This is her first assignment with MSF. 

Maeve in Karakalpakstan

Aboard the 21 hour train from Tashkent to Nukus, where the MSF programmeu is located, the sweat poured off me as I sat alone in my own compartment...

Maeve Lalor, MSF's Epidemiologist in Uzbekistan

My first weekend in Nukus all the expats that work for MSF were invited to the TB hospital’s Chief doctor’s birthday party.

This morning I joined one of the doctors at the MDR-TB hospital, which is set on the outskirts of Nukus on the edge of the desert.

This 18 year old has to take 22 pills every day

Last weekend, we baked in the sun within the inner walls of the city of Khiva- an ancient city on the silk route.

Khiva

This may be a good time to stop, think and reflect. This past month has been a very difficult one for our project both on a personal and...

The excitement built up towards the end of December as I went home for Christmas! I couldn’t wait to see my family and friends, eat a Christmas...

Tonight, I walked home from work in arctic conditions (-15C), clad in my balaclava it was difficult to breath.

January has been a marathon month of never ending data requests, summarising the project we just handed over to the Ministry of Health,...

The last few weeks have been very up and down. I’ve gone
from feeling extremely frustrated to excited and motivated. I find it amazing
how quickly...

I was truly surprised by the men of Karakalpakstan today! Lunch time in our office is one of my favourite parts of the day for me here.

It’s been almost three months since I left Karakalpakstan, and I’ve come to the International TB conference in France to present our findings...